Topics

Bio-Thera receives Chinese approval for Humira biosimilar

05:50 EST 8 Nov 2019 | Pharmaceutical Technology

Chinese pharmaceutical company Bio-Thera Solutions has received approval from the country’s National Medical Products Administration (NMPA) for Qletli, a biosimilar...
Read More...

The post Bio-Thera receives Chinese approval for Humira biosimilar appeared first on Pharmaceutical Technology.

Original Article: Bio-Thera receives Chinese approval for Humira biosimilar

NEXT ARTICLE

More From BioPortfolio on "Bio-Thera receives Chinese approval for Humira biosimilar"

Quick Search

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...